- Global Pharma News & Resources

Press Releases - 2019-10-10

Date Title Company
10-Oct-2019 Mezzion Pharma announces that it has conducted a Type C Meeting with the FDA Regarding the TOP Line Data from the FUEL Phase 3 Clinical Trial Mezzion Pharma Co. Ltd.
10-Oct-2019 Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration Kodiak Sciences Inc.
10-Oct-2019 Canavation Product Group Acquires Consumer Product Division From Teewinot Life Sciences Canavation Product Group
10-Oct-2019 Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity Jazz Pharmaceuticals plc
10-Oct-2019 IDEXX Laboratories to Release 2019 Third Quarter Financial Results IDEXX Laboratories, Inc.
10-Oct-2019 Women Of Color In Pharma Expands Reach With Annual Conference In Atlantic City, N.J. Women of Color in Pharma
10-Oct-2019 New Novodiag® Stool Parasites test allows rapid, accurate and cost-effective molecular testing for gastrointestinal infections Mobidiag Ltd
10-Oct-2019 Study data monitoring committee has confirmed the good tolerability of Clevegen up to 10mg/kg and confirmed Part I expansion to secure optimal dosing for part II of the MATINS study with advanced solid tumours Faron Pharmaceuticals Ltd
10-Oct-2019 Nordic Nanovector: Presentation at the Annual Congress of the European Association of Nuclear Medicine (EANM) Nordic Nanovector
10-Oct-2019 UCB Showcases Wealth of new Psoriasis Research at EADV 2019 UCB
10-Oct-2019 Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility Galderma
10-Oct-2019 Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection Merck
10-Oct-2019 GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer GE Healthcare and Theragnostics
10-Oct-2019 Novartis real-world evidence confirms high efficacy, long-term response and favorable safety profile of Cosentyx® in clinical practice Novartis Global External Communications
10-Oct-2019 Data to be Presented at AASLD 2019 Shows HighTide Lead Compound Improves NASH in Two Animal Models HighTide Therapeutics Inc.
10-Oct-2019 Vision attends Best Practice Show to share new strategy as part of Cegedim’s commitment to deliver a smarter, better and faster healthcare solution. Cegedim
10-Oct-2019 Regeneron to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2019 Regeneron Pharmaceuticals, Inc.
10-Oct-2019 On behalf of the private sector, (RED) increases Global Fund Replenishment pledge by 50%; commits to generating USD $150 million to fight AIDS over the coming three years (RED)
10-Oct-2019 Biofrontera AG: ​​​​​​​Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019 Biofrontera AG